Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Opinion
Video
Common Adverse Reactions to EGFR Therapy
Alan Chin, PharmD, BCOP, presents an overview of the most prevalent and common adverse reactions associated with EGFR-targeted therapies in metastatic NSCLC and shares strategies to mitigate toxicities, with a focus on managing dermatologic events such as rash and itching.
EP: 1.Exploring EGFR Mutations and Prevalence in Non-Small Cell Lung Cancer
EP: 2.Examining Key Data from the FLAURA2 and MIRAPOSA Trials
EP: 3.Analyzing the MARIPOSA-2 Trial Data’s Impact on Clinical Practice
EP: 4.Exploring Key Insights from the PAPILLON Trial
Now Viewing
EP: 5.Common Adverse Reactions to EGFR Therapy
EP: 6.Expert Insights on Managing Amivantamab Infusion Reactions, Dosing, and Medication
EP: 7.Impact of Emerging Therapies on Outcomes for EGFR-Mutated NSCLC
- Provide a broad overview of common adverse effects associated with EGFR-targeted therapies in metastatic NSCLC.
- What proactive strategies do you recommend for preventing dermatologic toxicities, such as rash and acneiform eruptions, in patients receiving EGFR-targeted therapies?
Related Videos
Related Content
